CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Two GLP-1 drugs — Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. ... helping people lose 15% to 20% of their body weight, equivalent to what they ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

GLP-1 analogs have been widely used to treat patients with type 2 diabetes in recent years ... 8–12% SDS–PAGE was used to resolve equivalent amounts of protein and was then transferred to ... 40, 65, ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

WEIGHT loss jabs could be rolled out by the NHS in pharmacies under plans to make them more widely available and “tackle the ...

European technology companies are commanding attention on the global stage, with several securing massive funding rounds that ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...